Kenya - English - Pharmacy and Poisons Board

medochemie ltd 1-10 constantinoupoleos st. 3011 limassol - cefuroxime axetil - coated tablet - cefuroxime axetil 500mg - beta-lactamantibacterials: second-generation

Kenya - English - Pharmacy and Poisons Board

medochemie ltd 1-10 constantinoupoleos st. 3011 limassol - irbesartan - tablet - irbersartan 150mg - agents acting on the renin-angiotensin system:

Kenya - English - Pharmacy and Poisons Board

medochemie ltd 1-10 constantinoupoleos st. 3011 limassol - irbesartan - tablet - irbesartan 300mg - agents acting on the renin-angiotensin system:

Kenya - English - Pharmacy and Poisons Board

medochemie ltd 1-10 constantinoupoleos st. 3011 limassol - flutamide - coated tablet - flutamide 250mg - plain antiandrogens

Kenya - English - Pharmacy and Poisons Board

medochemie ltd 1-10 constantinoupoleos st. 3011 limassol - clarithromycin 500mg - coated tablet - clarithromycin 500mg - antibacterials for systemic use: macrolides

Kenya - English - Pharmacy and Poisons Board

medochemie ltd 1-10 constantinoupoleos st. 3011 limassol - carbamazepine - tablet - carbamazepine 200mg - antiepileptics: carboxamidederivatives

Malta - English - Medicines Authority

medochemie limited 1-10 constantinoupleos street, 3011 limassol, cyprus - film-coated tablet - rivaroxaban 15 mg - antithrombotic agents

Malta - English - Medicines Authority

medochemie limited 1-10 constantinoupleos street, 3011 limassol, cyprus - film-coated tablet - rivaroxaban 20 mg - antithrombotic agents

Israel - English - Ministry of Health

devries & co. ltd - modafinil - tablets - modafinil 100 mg - modafinil - to improve wakefulness in patients with excessive sleepiness associated with narcolepsy (with or without cataplexy), obstructive sleep apnea/hypopnea syndrome (osahs ) and shift work sleep disorder (swds).

Israel - English - Ministry of Health

devries & co. ltd - entacapone - film coated tablets - entacapone 200 mg - entacapone - entacapone is indicated as an adjunct to standard preparations of levodopa/benserazide or levodopa/carbidopa for use in patients with parkinson`s disease and end-of-dose motor fluctuations who cannot be stabilised on those combinations.